
#Trade Shows & Events
MEDICA2024 | Tianlong , KHB and TGS join hands for the first time to create a new era of global diagnostics at overseas joint exhibition
Three companies join hands for the first time and appear on the global stage
From November 11th to 14th, Tianlong Technology appeared at MEDICA 2024 in Düsseldorf, Germany. This exhibition is one of the largest and most influential medical industry exhibitions in the world, which is not only a communication platform for the global healthcare industry, but also an important stage for displaying cutting-edge technologies and solutions in the industry.
Biolum Pro ATP hygiene monitoring system, which was independently developed by Tianlong Technology and won the German Red Dot Design Award, was presented at the exhibition. This lightweight handheld hygiene monitoring device can provide test results in as little as 10 seconds, with a sensitivity as high as 10-16mol ATP, making a big splash in the food safety and medical testing fields. Customers have said that it provides an efficient and accurate solution for rapid hygiene inspection on site, with a variety of application scenarios to meet the needs of different customers.
Among them, a regular customer from Serbia had an in-depth communication with Tianlong team at our booth about the expansion of molecular diagnostic market in Serbia. In the previous cooperation, the customer purchased Gentier X3 series real-time fluorescence PCR instrument from Tianlong, which adopts 32X3 independent module design and 96 samples throughput, and is able to run three different experimental projects at the same time or in separate time slots, which effectively enhances the efficiency and flexibility of the experiments. The customer highly evaluated and fully recognized the innovative technology of Gentier X3 and the perfect after-sales service of Tianlong. Based on the good cooperation experience, the customer indicated that they plan to further expand the purchase of Tianlong's extraction series and other PCR series instruments to meet the increasing diagnostic needs.
The MEDICA exhibition not only demonstrated the core product advantages of Tianlong Technology and group companies, but also provided an important opportunity to further expand the global market and strengthen customer cooperation. With the continuous development of our global business, we will continue to strengthen our presence in the European market and promote technological innovation and localized services.
In the future, Tianlong Technology and the Group will continue to deepen the existing market, further expand the global business territory, continue to expand the influence in the world, and help customers around the world to realize more efficient and accurate diagnosis and treatment.